scholarly journals The Immune Epitope Database and Analysis Resource Program 2003–2018: reflections and outlook

2019 ◽  
Vol 72 (1-2) ◽  
pp. 57-76 ◽  
Author(s):  
Sheridan Martini ◽  
Morten Nielsen ◽  
Bjoern Peters ◽  
Alessandro Sette
2018 ◽  
Vol 9 ◽  
Author(s):  
Swapnil Mahajan ◽  
Randi Vita ◽  
Deborah Shackelford ◽  
Jerome Lane ◽  
Veronique Schulten ◽  
...  

Author(s):  
Anjali Dhall ◽  
Sumeet Patiyal ◽  
Neelam Sharma ◽  
Salman Sadullah Usmani ◽  
Gajendra P S Raghava

Abstract Interleukin 6 (IL-6) is a pro-inflammatory cytokine that stimulates acute phase responses, hematopoiesis and specific immune reactions. Recently, it was found that the IL-6 plays a vital role in the progression of COVID-19, which is responsible for the high mortality rate. In order to facilitate the scientific community to fight against COVID-19, we have developed a method for predicting IL-6 inducing peptides/epitopes. The models were trained and tested on experimentally validated 365 IL-6 inducing and 2991 non-inducing peptides extracted from the immune epitope database. Initially, 9149 features of each peptide were computed using Pfeature, which were reduced to 186 features using the SVC-L1 technique. These features were ranked based on their classification ability, and the top 10 features were used for developing prediction models. A wide range of machine learning techniques has been deployed to develop models. Random Forest-based model achieves a maximum AUROC of 0.84 and 0.83 on training and independent validation dataset, respectively. We have also identified IL-6 inducing peptides in different proteins of SARS-CoV-2, using our best models to design vaccine against COVID-19. A web server named as IL-6Pred and a standalone package has been developed for predicting, designing and screening of IL-6 inducing peptides (https://webs.iiitd.edu.in/raghava/il6pred/).


2017 ◽  
Vol 8 ◽  
Author(s):  
Ward Fleri ◽  
Sinu Paul ◽  
Sandeep Kumar Dhanda ◽  
Swapnil Mahajan ◽  
Xiaojun Xu ◽  
...  

2005 ◽  
Vol 57 (5) ◽  
pp. 326-336 ◽  
Author(s):  
Bjoern Peters ◽  
John Sidney ◽  
Phil Bourne ◽  
Huynh-Hoa Bui ◽  
Soeren Buus ◽  
...  

2016 ◽  
Vol 12 (4) ◽  
pp. 2982-2984
Author(s):  
Shaimaa Sait ◽  
Timothy Fawcett ◽  
George Blanck

2020 ◽  
Author(s):  
Sahar Obi Abd Albagi ◽  
Mosab Yahya Al-Nour ◽  
Mustafa Elhag ◽  
Asaad Tageldein Idris Abdelihalim ◽  
Esraa Musa Haroun ◽  
...  

AbstractDue to the current COVID-19 pandemic, the rapid discovery of a safe and effective vaccine is an essential issue, consequently, this study aims to predict potential COVID-19 peptide-based vaccine utilizing the Nucleocapsid phosphoprotein (N) and Spike Glycoprotein (S) via the Immunoinformatics approach. To achieve this goal, several Immune Epitope Database (IEDB) tools, molecular docking, and safety prediction servers were used. According to the results, The Spike peptide peptides SQCVNLTTRTQLPPAYTNSFTRGVY is predicted to have the highest binding affinity to the B-Cells. The Spike peptide FTISVTTEI has the highest binding affinity to the MHC I HLA-B1503 allele. The Nucleocapsid peptides KTFPPTEPK and RWYFYYLGTGPEAGL have the highest binding affinity to the MHC I HLA-A0202 allele and the three MHC II alleles HLA-DPA1*01:03/DPB1*02:01, HLA-DQA1*01:02/DQB1- *06:02, HLA-DRB1, respectively. Furthermore, those peptides were predicted as non-toxic and non-allergen. Therefore, the combination of those peptides is predicted to stimulate better immunological responses with respectable safety.


2018 ◽  
Vol 17 (30) ◽  
pp. 3249-3255 ◽  
Author(s):  
Severo Vazquez- Prieto ◽  
Esperanza Paniagua ◽  
Hugo Solana ◽  
Florencio M. Ubeira

2010 ◽  
Vol 39 (Database) ◽  
pp. D1164-D1170 ◽  
Author(s):  
J. Ponomarenko ◽  
N. Papangelopoulos ◽  
D. M. Zajonc ◽  
B. Peters ◽  
A. Sette ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document